<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We undertook a retrospective review of <z:hpo ids='HP_0000001'>all</z:hpo> 76 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> transplanted between August 1986 and March 1995 at our center </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received melphalan (140-160 mg/m2), <z:chebi fb="0" ids="4911">etoposide</z:chebi> (60 mg/kg) and total body irradiation </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had bone marrow cytogenetic analysis at regular intervals following ABMT </plain></SENT>
<SENT sid="3" pm="."><plain>The primary study end point was the development of the new cytogenetic abnormalities </plain></SENT>
<SENT sid="4" pm="."><plain>Secondary end points were the development of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Sixty-two of 77 patients were alive at least 6 months post transplant </plain></SENT>
<SENT sid="6" pm="."><plain>Cytogenetic abnormalities developed in 7/62 patients (11%) following ABMT </plain></SENT>
<SENT sid="7" pm="."><plain>No patients demonstrated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>At a median of 30 months after development of the cytogenetic abnormality, only one patient developed features suggestive but not diagnostic of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> seven patients remain alive and <z:hpo ids='HP_0001909'>leukemia</z:hpo>-free up to 70 months after detection of the abnormal clone </plain></SENT>
<SENT sid="10" pm="."><plain>There was no increased incidence of cytogenetic abnormalities developing in patients receiving a purged autograft </plain></SENT>
<SENT sid="11" pm="."><plain>New cytogenetic abnormalities are frequent following ABMT for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> but do not appear to predict development of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> or <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>These abnormalities may relate to use of total body radiation as part of the high-dose therapy </plain></SENT>
</text></document>